Bioxytran annual free cash flow
2021
2022
2023
2024
2025
Bioxytran Free Cash Flow (FCF) History (BIXT)
Bioxytran reported −$549,546 in free cash flow for fiscal 2025, a decrease of $140,036 from the previous fiscal year.
View full Bioxytran company overviewBioxytran free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$549,546 | −$140,036 | — | — |
| 2024 | 2024-12-31 | −$409,510 | $410,166 | — | — |
| 2023 | 2023-12-31 | −$819,676 | $1.0M | — | — |
| 2022 | 2022-12-31 | −$1.8M | −$101,587 | — | — |
| 2021 | 2021-12-31 | −$1.7M | — | — | — |
Bioxytran quarterly free cash flow
Q3.13
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$359,156 | −$273,307 | — | — |
| Q1 2026 | 2026-03-31 | −$247,837 | −$80,499 | — | — |
| Q4 2025 | 2025-12-31 | −$243,211 | −$103,203 | — | — |
| Q3 2025 | 2025-09-30 | −$53,148 | $31,220 | — | — |
| Q2 2025 | 2025-06-30 | −$85,849 | −$14,891 | — | — |
| Q1 2025 | 2025-03-31 | −$167,338 | −$51,776 | — | — |
| Q4 2024 | 2024-12-31 | −$140,008 | −$40,821 | — | — |
| Q3 2024 | 2024-09-30 | −$84,368 | $270,901 | — | — |
| Q2 2024 | 2024-06-30 | −$70,958 | $102,662 | — | — |
| Q1 2024 | 2024-03-31 | −$115,562 | $76,038 | — | — |
| Q4 2023 | 2023-12-31 | −$99,187 | $57,602 | — | — |
| Q3 2023 | 2023-09-30 | −$355,269 | $371,218 | — | — |
| Q2 2023 | 2023-06-30 | −$173,620 | $65,287 | — | — |
| Q1 2023 | 2023-03-31 | −$191,600 | $522,134 | — | — |
| Q4 2022 | 2022-12-31 | −$156,789 | — | — | — |
| Q3 2022 | 2022-09-30 | −$726,487 | −$582,438 | — | — |
| Q2 2022 | 2022-06-30 | −$238,907 | — | — | — |
| Q1 2022 | 2022-03-31 | −$713,734 | — | — | — |
| Q3 2021 | 2021-09-30 | −$144,049 | — | — | — |
| Q3 2013 | 2013-09-30 | $5,454 | — | — | +9.79% |
Bioxytran free cash flow growth trends
Bioxytran's latest reported quarter, Q2 2026, generated −$359,156 in free cash flow, a decrease of $273,307 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bioxytran source filings ↗